Comments

BioCryst Pharma Stock Guidance

BCRXNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$7.40
0.182.49%
At close: -
$7.38
-0.02-0.27%
After Hours: 5:48 PM EDT
BioCryst Pharma (BCRX) ForecastNewsEarningsBioCryst Pharma (BCRX) Options

Guidance

DividendsAnalyst RatingsInsider TradesGovernment TradesShort Interest

BioCryst Pharma Stock Guidance | NASDAQ:BCRX | Benzinga

BioCryst Pharma issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
02/24/2025BCRX
BioCryst Pharma
FY2025———$560.00M$575.00M$628.83MGet Alert
01/10/2025BCRX
BioCryst Pharma
FY2024———$450.00M$450.00M$446.22MGet Alert
01/10/2025BCRX
BioCryst Pharma
Q42024———$130.80M$130.80M$128.65MGet Alert
01/10/2025BCRX
BioCryst Pharma
FY2025———$540.00M$560.00M$533.76MGet Alert

FAQ

Q

What is the most recent guidance for BioCryst Pharma (BCRX)?

A

There have been no specific sales or earnings guidance reported for BioCryst Pharma in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved